Literature DB >> 30521035

Determinants of medication adherence among chronic patients from an urban area: a cross-sectional study.

Neus Pagès-Puigdemont1, Laura Tuneu2, Montserrat Masip1, Pere Valls3, Teresa Puig4,5, Maria Antònia Mangues1,6.   

Abstract

BACKGROUND: Medication adherence is a complex area of behaviour. Little is known about what influences chronic patients to take their medicines. This study has aimed to compare and contrast the health-related beliefs, experiences and types of behaviour typical among patients who have at least one chronic condition and are following a pharmacological treatment in accordance with their level of medication adherence.
METHODS: A questionnaire-based cross-sectional study, consisting of socio-demographic data, the 4-item Morisky-Green scale and 37 statements about health beliefs, perceptions and experiences, was conducted at different levels of healthcare (primary and tertiary settings).
RESULTS: A total of 577 questionnaires were analyzed. Respondents had a mean age of 64 and took an average of 4.6 drugs. Optimal adherence was reported by 58.6% of respondents. Bivariate analysis showed adherent subjects were older, took more medications, were in better spirits and had greater confidence and information regarding their treatment. Multivariate analysis found older age and the statements 'My doctor periodically reviews my treatment' and 'I am motivated to continue with the treatment' to be significantly related to medication adherence, while 'I make variations when taking medication depending on how I feel' was significant for medication non-adherence.
CONCLUSION: Medication non-adherence is common among chronic patients. Patient-centred approaches should be implemented in daily clinical practice as patient health beliefs, experiences and conduct influence medication-taking. Motivational interviewing might improve medication adherence in permitting emotional state managing and increasing educational skills, patient motivation and confidence between patients and healthcare providers.
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30521035     DOI: 10.1093/eurpub/cky259

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  5 in total

Review 1.  Hypertension and Drug Adherence in the Elderly.

Authors:  Michel Burnier; Erietta Polychronopoulou; Gregoire Wuerzner
Journal:  Front Cardiovasc Med       Date:  2020-04-07

2.  Different Associations of Intentional and Non-Intentional Non-Adherence Behaviors with Patient Experience with Healthcare and Patient Beliefs in Medications: A Survey of Patients with Chronic Conditions.

Authors:  Luis Cea-Calvo; Ignacio Marín-Jiménez; Javier de Toro; María J Fuster-RuizdeApodaca; Gonzalo Fernández; Nuria Sánchez-Vega; Domingo Orozco-Beltrán
Journal:  Patient Prefer Adherence       Date:  2020-12-14       Impact factor: 2.711

3.  Relationship of an adherence score with blood pressure control status among patients with hypertension and their determinants: Findings from a nationwide blood pressure screening program.

Authors:  Yook Chin Chia; Navin Kumar Devaraj; Siew Mooi Ching; Pei Boon Ooi; Ming Tsuey Chew; Bee Nah Chew; Mohazmi Mohamed; Hooi Min Lim; Hooi Chin Beh; Azli Shahril Othman; Hanis Saadah Husin; Abdul Hafiz Mohamad Gani; Dalyana Hamid; Pei San Kang; Chai Li Tay; Ping Foo Wong; Haslinda Hassan
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-14       Impact factor: 3.738

4.  Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization.

Authors:  Cinzia Di Novi; Lucia Leporatti; Rosella Levaggi; Marcello Montefiori
Journal:  J Econ Behav Organ       Date:  2022-10-14

5.  Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study.

Authors:  Cesar I Fernandez-Lazaro; Juan M García-González; David P Adams; Diego Fernandez-Lazaro; Juan Mielgo-Ayuso; Alberto Caballero-Garcia; Francisca Moreno Racionero; Alfredo Córdova; Jose A Miron-Canelo
Journal:  BMC Fam Pract       Date:  2019-09-14       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.